4//SEC Filing
HI TECH PHARMACAL CO INC 4
Accession 0001566028-13-000018
CIK 0000887497operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 12:42 PM ET
Size
19.9 KB
Accession
0001566028-13-000018
Insider Transaction Report
Form 4
GOLDWYN MARTIN M
Director
Transactions
- Exercise/Conversion
Common Stock
2013-09-27$13.50/sh+4,308$58,158→ 4,308 total - Other
Common Stock
2013-09-30−3,111→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-09-27−4,308→ 3,111 totalExercise: $13.50From: 2004-11-28Exp: 2013-11-28→ Common Stock (4,308 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2013-09-30−3,111→ 0 totalExercise: $13.50From: 2004-11-28Exp: 2013-11-28→ Common Stock (3,111 underlying) - Exercise/Conversion
Common Stock
2013-09-27$24.95/sh+3,000$74,850→ 3,000 total - Exercise/Conversion
Common Stock
2013-09-30$13.50/sh+3,111$41,999→ 3,111 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-09-27−3,000→ 9,375 totalExercise: $24.95From: 2006-11-08Exp: 2015-11-08→ Common Stock (3,000 underlying) - Other
Common Stock
2013-09-27−4,308→ 0 total - Sale
Common Stock
2013-09-27$43.10/sh−3,000$129,300→ 0 total
Footnotes (5)
- [F1]The shares acquired upon exercise of the options reflected on this form were immediately distributed without consideration to a partner or partners in Mr. Goldwyn's law firm.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $43.15, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
- [F3]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
- [F4]The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F5]Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.
Documents
Issuer
HI TECH PHARMACAL CO INC
CIK 0000887497
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000887497
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 12:42 PM ET
- Size
- 19.9 KB